Mary DeVience’s Post

What would you have done differently if you had anticipated the likelihood of a global pandemic or the explosion of generative AI? In our new podcast Imagine This..., spend time with BCG’s editor in chief, our conversational AI agent GENE, and BCG experts as they focus on what could lie ahead for our world—and how you should prepare your business today. https://on.bcg.com/42MHose

By 2030, the best CIO might be a CIB: a chief intelligence bot. And the human CEO might be bolstered by a swarm of CEO bots, able to harness a vast diversity of perspectives. Can you imagine?

I’m biased of course having worked at Boston Consulting Group (BCG), but I think they’re arguably the company innovating most on branded company podcasts formats leveraging AI: - - - CEO Digest - - - With this newly launched show, BCG has two ongoing podcasts that feature AI not just as a discussion topic or a production tool, but actually a co-host on mic. The other show that started their GenAI-as-host efforts was “Imagine This…” (which I reviewed back in March), in which BCG Editor in Chief Paul Michelman engages in conversation with “GENE”, a generative AI bot, about tech innovation and AI topics. CEO Digest combines GENE with another relevant topic for a thought leadership show - synthesized insights from BCG’s written articles for business executives. They certainly could have taken a more traditional route of having human hosts and authors of the material discussing the work. It’s novel and impressive to take the approach of having AI providing the takeaway points. It shows how far AI capabilities have come, and Paul and the production team is still willing to point out when the tech still has shortcomings. There are a ton of general and branded AI podcasts you can listen to now - I’d recommend these BCG ones as shows that are embracing and putting into practice AI, not just talking about it!

Our latest episode of the Alldus, “AI in Action” Podcast features Drew Linsley from Operant Biopharma. Here Drew talks us through his journey and how Operant are using AI to autonomously design biological experiments, discovering and optimizing disease treatments. It’s another example of the groundbreaking work across the AI world. If you are a business leader doing innovative work in AI and would be interested in featuring on the podcast, we’d love to hear from you. #biopharma #artificialintelligence #aiinaction

In S5E04 of our podcast, Two Scientists Walk Into A Bar, antibody engineers Yan Wu and Paul Carter discuss initial obstacles they've faced in this challenging field, antibody engineering advances they're excited about, and how computational methods like AI will continue transforming antibody discovery and development. Listen to the full episode: http://spr.ly/6042gmjk4

Dr. Na-Ri Oh and Ian Wendt here, and we couldn’t be more thrilled to share our latest The RealPharma Podcast episode with you. This time, we’re diving deep into the world of #ArtificialIntelligence / #AI in #Pharma with the incredible Dr. Andrée Bates. 🌟 Andree, the CEO of Eularis, is a true visionary in the field, and her insights are nothing short of groundbreaking. Whether you're a seasoned professional or just curious about AI's role in #healthcare, this episode is packed with valuable information. 🔍 We cover everything from: - How AI is revolutionizing drug discovery. - The ethical considerations we need to solve. - Real-world examples of AI making a difference in #patient outcomes. Andree’s passion for merging technology with healthcare is contagious, and we promise you’ll walk away feeling inspired and informed. 💡 Tune in to hear about the future of Pharma, the challenges we face, and the incredible potential that lies ahead. This episode is all about pushing boundaries and reimagining what’s possible. Listen here: https://lnkd.in/gMs9CkQg

A great listen! @Jason Park discusses the @Empress approach to small molecule #drugdiscovery.

Google's has released it's new Alphafold 3 AI model which outpaces it's predecessor, Alphafold 2. The new model can process DNA, RNA, and 'all life's molecules'. What does this mean for medical science, agriculture and other industries? Is this development underhyped given its potential impact on the future of society? Watch on YouTube: https://lnkd.in/gSWbU6Mc From the Briefly Creo Podcast - Tech Headlines, Episode 1 Recorded on 16 May 2024 Watch the full episode here: https://lnkd.in/gYp56yfr Watch or listen to the Briefly Creo Podcast on all platforms, including YouTube, Spotify, Apple Podcasts, and Audible. Find us on socials: @creolegalau Our website: https://creolegal.au #tech #auslaw #techlaw #techlawyer #AI #ailawyer #iplaw #iplawyer #intellectualproperty #openai #chatgpt #googleai #deepmind #googledeepmind #biomedicalresearch #bioscience #medicalscience #alphafold #alphafold3

On this last episode of the Biotech Bytes Podcast, Steve was joined by Rajvir (Raj) Madan, Chief Digital and Technology Officer at Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), where we break down the transformative impact AI is having in our field. Their discussion spans from the reduction of drug discovery timelines to addressing ethical concerns related to data biases. We also confront challenges tied to data quality and the implications for the workforce in the era of AI. To grasp the full spectrum of AI's influence on biotech and the vision it's charting for our future, tune in for a compelling episode. 👉 https://buff.ly/498iEgq #podcast #pharma #biotech #databiases #dataquality #data #ai #technology #IT

Thanks, Daniel Levine, for this opportunity to talk about what makes Aulos Bioscience unique in our approach and how AU-007 is a promising therapeutic agent for cancer in the IL-2 space. What a great discussion, as always. #science #innovation